Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
400 results:

  • 1. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and foxp3 in colorectal cancer draining lymph nodes.
    Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
    Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
    Chen Q; Deng Y; Li Y; Chen J; Zhang R; Yang L; Guo R; Xing B; Ding P; Cai J; Zhao H
    Cancer Lett; 2024 Apr; 588():216778. PubMed ID: 38458593
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells.
    Ding R; Yu X; Hu Z; Dong Y; Huang H; Zhang Y; Han Q; Ni ZY; Zhao R; Ye Y; Zou Q
    Immunity; 2024 Mar; 57(3):528-540.e6. PubMed ID: 38417442
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Evaluating CD4 and foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and colorectal cancer Patients.
    Asri N; Nazemalhosseini Mojarad E; Taleghani MY; Houri H; Saeedi Niasar M; Rezaei-Tavirani M; Jahani-Sherafat S; Shahbazkhani A; Nikzamir A; Ehsani Ardakani MJ; Khodadost M; Rostami-Nejad M
    Asian Pac J Cancer Prev; 2024 Feb; 25(2):647-652. PubMed ID: 38415552
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
    Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
    Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
    Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
    Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
    Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
    Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction.
    Shiri AM; Zhang T; Bedke T; Zazara DE; Zhao L; Lücke J; Sabihi M; Fazio A; Zhang S; Tauriello DVF; Batlle E; Steglich B; Kempski J; Agalioti T; Nawrocki M; Xu Y; Riecken K; Liebold I; Brockmann L; Konczalla L; Bosurgi L; Mercanoglu B; Seeger P; Küsters N; Lykoudis PM; Heumann A; Arck PC; Fehse B; Busch P; Grotelüschen R; Mann O; Izbicki JR; Hackert T; Flavell RA; Gagliani N; Giannou AD; Huber S
    J Hepatol; 2024 Apr; 80(4):634-644. PubMed ID: 38160941
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrin-linked kinase expression in myeloid cells promotes colon tumorigenesis.
    Ahmed AU; Almasabi S; Firestein R; Williams BRG
    Front Immunol; 2023; 14():1270194. PubMed ID: 38077324
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. foxp3-regulated lncRNA NONHSAT136151 promotes colorectal cancer progression by disrupting QKI interaction with target mRNAs.
    Huang H; Liang X; Wu W; Yuan T; Chen Z; Wang L; Wu Z; Zhang T; Yang K; Wen K
    J Cell Mol Med; 2024 Jan; 28(2):e18068. PubMed ID: 38041531
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
    Edin S; Gylling B; Li X; Stenberg Å; Löfgren-Burström A; Zingmark C; van Guelpen B; Ljuslinder I; Ling A; Palmqvist R
    Br J Cancer; 2024 Jan; 130(1):143-150. PubMed ID: 38040818
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Clinical significance of programmed cell death-ligand expression in small bowel adenocarcinoma is determined by the tumor microenvironment.
    Hoshimoto A; Tatsuguchi A; Hamakubo R; Nishimoto T; Omori J; Akimoto N; Tanaka S; Fujimori S; Hatori T; Shimizu A; Iwakiri K
    World J Gastroenterol; 2023 Oct; 29(40):5566-5581. PubMed ID: 37970475
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Propolis Has an Anticancer Effect on Early Stage colorectal cancer by Affecting Epithelial Differentiation and Gut Immunity in the Tumor Microenvironment.
    Shen MH; Liu CY; Chang KW; Lai CL; Chang SC; Huang CJ
    Nutrients; 2023 Oct; 15(21):. PubMed ID: 37960147
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. A Metabolic Gene Survey Pinpoints Fucosylation as a Key Pathway Underlying the Suppressive Function of Regulatory T Cells in cancer.
    Pinioti S; Sharma H; Flerin NC; Yu Q; Tzoumpa A; Trusso Cafarello S; De Bousser E; Callewaert N; Oldenhove G; Schlenner S; Thienpont B; Garg AD; Di Matteo M; Mazzone M
    Cancer Immunol Res; 2023 Dec; 11(12):1611-1629. PubMed ID: 37933083
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Crosstalk within peripheral blood mononuclear cells mediates anti-inflammatory effects of n-3 PUFA-rich lipid emulsions in parenteral nutrition.
    Wawrzyniak P; Hubeli B; Wawrzyniak M; Noureddine N; Walberg A; Scharl S; Turina M; Scharl M; Zaugg M; Krämer SD; Rogler G; Hersberger M
    Clin Nutr; 2023 Dec; 42(12):2422-2433. PubMed ID: 37871483
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Expanding CYLD protein in NF-κβ/TNF-α signaling pathway in response to Lactobacillus acidophilus in non-metastatic rectal cancer patients.
    Zamani F; Khalighfard S; Kalhori MR; Poorkhani A; Amiriani T; Hosseinzadeh P; Esmati E; Alemrajabi M; Nikoofar A; Safarnezhad Tameshkel F; Alizadeh AM
    Med Oncol; 2023 Sep; 40(10):302. PubMed ID: 37725175
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Accounting for intensity variation in image analysis of large-scale multiplexed clinical trial datasets.
    Frei AL; McGuigan A; Sinha RR; Glaire MA; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson TJ; Saunders M; Oein K; Maka N; Pezella F; Campo L; Hay J; Edwards J; Sansom OJ; Kelly C; Tomlinson I; Kildal W; Kerr RS; Kerr DJ; Danielsen HE; Domingo E; ; Church DN; Koelzer VH
    J Pathol Clin Res; 2023 Nov; 9(6):449-463. PubMed ID: 37697694
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. HLA Class I Expression Is Associated with DNA Damage and Immune Cell Infiltration into Dysplastic and Neoplastic Lesions in Ulcerative Colitis.
    Okami H; Ozawa N; Sohda M; Yokobori T; Osone K; Erkhem-Ochir B; Dorjkhorloo G; Shiraishi T; Okada T; Sano A; Sakai M; Miyazaki T; Ogawa H; Yao T; Oike T; Sato H; Shirabe K; Shibata A; Saeki H
    Int J Mol Sci; 2023 Sep; 24(17):. PubMed ID: 37686454
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. MAdCAM-1 targeting strategy can prevent colitic cancer carcinogenesis and progression via suppression of immune cell infiltration and inflammatory signals.
    Ozawa N; Yokobori T; Osone K; Bilguun EO; Okami H; Shimoda Y; Shiraishi T; Okada T; Sano A; Sakai M; Sohda M; Miyazaki T; Ide M; Ogawa H; Yao T; Oyama T; Shirabe K; Saeki H
    Int J Cancer; 2024 Jan; 154(2):359-371. PubMed ID: 37676657
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. pH-Responsive Zinc Ion Regulating Immunomodulatory Nanoparticles for Effective cancer Immunotherapy.
    Lim B; Kim KS; Na K
    Biomacromolecules; 2023 Sep; 24(9):4263-4273. PubMed ID: 37616157
    [TBL] [Abstract] [Full Text] [Related]  


    of 20.